Conditional Long-Term Survival after Autologous Hematopoietic Cell Transplantation for Diffuse Large B Cell Lymphoma

This publication has 17 references indexed in Scilit:

• Long‐term outcomes among 2‐year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b‐cell lymphoma
  Cancer, 2017
• Hematopoietic cell transplantation for diffuse large B-cell and follicular lymphoma
  Hematology/Oncology and Stem Cell Therapy, 2017
• Clinical and treatment‐related features determining the risk of late relapse in patients with diffuse large B‐cell lymphoma
  British Journal of Haematology, 2017
• A national study on conditional survival, excess mortality and second cancer after high dose therapy with autologous stem cell transplantation for non‐Hodgkin lymphoma
  British Journal of Haematology, 2016
• Post-autologous transplant maintenance therapies in lymphoid malignancies: are we there yet?
  Bone Marrow Transplantation, 2015
• Trends in Use of and Survival after Autologous Hematopoietic Cell Transplantation in North America, 1995-2005: Significant Improvement in Survival for Lymphoma and Myeloma during a Period of Increasing Recipient Age
  Transplantation and Cellular Therapy, 2013
• Surviving the cure: long term followup of hematopoietic cell transplant recipients
  Bone Marrow Transplantation, 2013
• Conditional survival and cause-specific mortality after autologous hematopoietic cell transplantation for hematological malignancies
  Leukemia, 2012
• Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study
  Blood, 2005
• Comparing Survival of a Sample to That of a Standard Population
  JNCI: Journal of the National Cancer Institute, 2003